Severe preeclampsia. Prediction of induced preterm birth
AbstractHypertensive disorders during pregnancy, mainly preeclampsia, occupy a leading position in the structure of causes of induced preterm birth. Prognostic models can be decisive in the early diagnosis of indications for induced preterm birth in preeclampsia. In the article, the authors analyzed data from analytical literature reviews covering this problem. Today, it is especially relevant to develop an optimized approach to the management of women with severe preeclampsia, predicting complications, and choosing the optimal timing of delivery of a premature pregnancy.
Keywords:preeclampsia; induced preterm birth; pregnancy; prognostic models
Funding. The study had no sponsor support.
Conflict of interest. The authors declare no conflict of interest.
For citation: Spitsyna M.A., Solovyeva A.V., Aleynikova E.Yu., Mamchich D.S. Severe preeclampsia. Prediction of induced preterm birth. Akusherstvo i ginekologiya: novosti, mneniya, obuchenie [Obstetrics and Gynecology: News, Opinions, Training]. 2024; 12. Supplement: 111–5. DOI: https://doi.org/10.33029/2303-9698-2024-12-suppl-111-115 (in Russian)
REFERENCES
1. Radzinsky V.E. Obstetric aggression, v. 2.0. Moscow: Redaktsiya zhurnala StatusPraesens, 2017: 872 p. ISBN 978-5-9908735-1-3. (in Russian)
2. Valencia C.M., Mol B.W., Jacobsson B.; FIGO Working Group for Preterm Birth. Response: FIGO good practice recommendations on modifiable causes of iatrogenic preterm birth. Int J Gynaecol Obstet. 2022; 159 (1): 335. DOI: https://doi.org/10.1002/ijgo.14346 Epub 2022 Jul 25. PMID: 35875842.
3. Aughey H., Jardine J., Knight H., Gurol-Urganci I., Walker K., Harris T., et al.; NMPA Project Team. Iatrogenic and spontaneous preterm birth in England: a population-based cohort study. BJOG. 2023; 130 (1): 33–41. DOI: https://doi.org/10.1111/1471-0528.17291 Epub 2022 Oct 3. PMID: 36073305; PMCID: PMC10092353.
4. Chawanpaiboon S., Vogel J.P., Moller A.B., Lumbiganon P., Petzold M., Hogan D., et al. Global, regional, and national estimates of levels of preterm birth in 2014: a systematic review and modelling analysis. Lancet Glob Health. 2019; 7 (1): e37–46. DOI: https://doi.org/10.1016/S2214-109X(18)30451-0 Epub 2018 Oct 30. PMID: 30389451; PMCID: PMC6293055.
5. Burger R.J., Temmink J.D., Wertaschnigg D., Ganzevoort W., Reddy M., Davey M.A., et al. Trends in singleton preterm birth in Victoria, 2007 to 2017: a consecutive cross-sectional study. Acta Obstet Gynecol Scand. 2021; 100 (7): 1230–8. DOI: https://doi.org/10.1111/aogs.14074 Epub 2021 Feb 12. PMID: 33382080; PMCID: PMC8359202.
6. Grétarsdóttir Á.S., Aspelund T., Steingrímsdóttir Th., Bjarnadóttir R.I., Einarsdóttir K. Preterm births in Iceland 1997–2016: preterm birth rates by gestational age groups and type of preterm birth. Birth. 2020; 47 (1): 105–14. DOI: https://doi.org/10.1111/birt.12467 Epub 2019 Nov 19. PMID: 31746027.
7. Cavoretto P.I., Giorgione V., Sotiriadis A., Viganò P., Papaleo E., Galdini A., et al. IVF/ICSI treatment and the risk of iatrogenic preterm birth in singleton pregnancies: systematic review and meta-analysis of cohort studies. J Matern Fetal Neonatal Med. 2022; 35 (10): 1987–96. DOI: https://doi.org/10.1080/14767058.2020.1771690 Epub 2020 Jun 4. PMID: 32498576.
8. Kietpeerakool C., Lumbiganon P., Laopaiboon M., Rattanakanokchai S., Vogel J.P., Gülmezoglu A.M. Pregnancy outcomes of women with previous caesarean sections: secondary analysis of World Health Organization Multicountry Survey on Maternal and Newborn Health. Sci Rep. 2019; 9 (1): 9748.
9. Liu Y.X., Xu F.L., Duan W.L., Dong H.F., Wang Y.J., Zhang Y., et al. [A multicenter study of the birth condition of preterm infants and the causes of preterm birth in Henan Province, China]. Zhongguo Dang Dai Er Ke Za Zhi. 2021; 23 (2): 121–6. [in Chinese]. DOI: https://doi.org/10.7499/j.issn.1008-8830.2010063 PMID: 33627204; PMCID: PMC7921542.
10. Clinical recommendations. Preeclampsia. Eclampsia. Edema, proteinuria and hypertensive disorders during pregnancy, childbirth and the postpartum period. Moscow: Ministerstvo zdravookhraneniya Rossiyskoy Federatsii, 2021. (in Russian)
11. Čehovin K., Gortnar A., Verdenik I., Lučovnik M., Kornhauser-Cerar L., Grosek Š. Comparison of neonatal morbidity and mortality following spontaneous and medically indicated preterm births: a retrospective population-based study using data from the Slovenian National Perinatal Information System 2013–2018. Med Sci Monit. 2023; 29: e938941. DOI: https://doi.org/10.12659/MSM.938941 PMID: 36740819; PMCID: PMC9912692.
12. Kim H., Shin Y.M., Lee K.N., Kim H.J., Jung Y.H., Park J.Y., et al. Neonatal outcomes of early preterm births according to the delivery indications. Early Hum Dev. 2023; 186: 105873. DOI: https://doi.org/10.1016/j.earlhumdev.2023.105873 Epub 2023 Oct 11. PMID: 37844515.
13. Remneva O.V., Korenovsky Y.V., Hovalyg N.M., et al. Induced preterm birth: evaluation of oxidative status, matrix metalloproteinases and their tissue inhibitors in amniotic fluid. Nauchnye rezul’taty biomeditsinskikh issledovaniy [Scientific Results of Biomedical Research]. 2021; 7 (1): 86–95. DOI: https://doi.org/10.18413/2658-6533-2020-7-1-0-9 (in Russian)
14. Poon L.C., Shennan A., Hyett J.A., Kapur A., Hadar E., Divakar H., et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention. Int J Gynaecol Obstet. 2019; 145 (suppl 1): 1–33. DOI: https://doi.org/10.1002/ijgo.12802 PMID: 31111484; PMCID: PMC6944283.
15. Bouter A.R., Duvekot J.J. Evaluation of the clinical impact of the revised ISSHP and ACOG definitions on preeclampsia. Pregnancy Hypertens. 2020; 19: 206–11. DOI: https://doi.org/10.1016/j.preghy.2019.11.011 Epub 2019 Dec 11. PMID: 31836469.
16. Simukhina M.A. Severe forms of preeclampsia. Clinical course in modern conditions: Autoabstract of the Diss. Moscow, 2019: 25 p. (in Russian)
17. Burton G.J., Redman C.W., Roberts J.M., Moffett A. Pre-eclampsia: pathophysiology and clinical implications. BMJ. 2019; 366: l2381. DOI: https://doi.org/10.1136/bmj.l2381 PMID: 31307997.
18. Armaly Z., Jadaon J.E., Jabbour A., Abassi Z.A. Preeclampsia: novel mechanisms and potential therapeutic approaches. Front Physiol. 2018; 9: 973. DOI: https://doi.org/10.3389/fphys.2018.00973 PMID: 30090069; PMCID: PMC6068263.
19. Roberts J.M., Rich-Edwards J.W., McElrath T.F., Garmire L., Myatt L.; Global Pregnancy Collaboration. Subtypes of preeclampsia: recognition and determining clinical usefulness. Hypertension. 2021; 77 (5): 1430–41. DOI: https://doi.org/10.1161/HYPERTENSIONAHA.120.14781 Epub 2021 Mar 29. PMID: 33775113; PMCID: PMC8103569.
20. Ukah U.V., Payne B., Karjalainen H., Kortelainen E., Seed P.T., Conti-Ramsden F.I., et al. Temporal and external validation of the fullPIERS model for the prediction of adverse maternal outcomes in women with pre-eclampsia. Pregnancy Hypertens. 2019; 15: 42–50. DOI: https://doi.org/10.1016/j.preghy.2018.01.004
21. von Dadelszen P., Payne B., Li J., Ansermino J.M., Broughton Pipkin F., Côté A.M., et al.; PIERS Study Group. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model. Lancet. 2011; 377 (9761): 219–27. DOI: https://doi.org/10.1016/S0140-6736(10)61351-7 Epub 2010 Dec 23. PMID: 21185591.
22. Payne B., Hutcheon J.A., Qu Z., Haniff F., Bhutta Z., Biryabarema C., et al.; PIERS Study Group. OS037. Minipiers (pre-eclampsia integrated estimate of risk): development of a clinical prediction model for use in low and middleincome countries (LMIC). Pregnancy Hypertens. 2012; 2 (3): 195–6. DOI: https://doi.org/10.1016/j.preghy.2012.04.038 Epub 2012 Jun 13. PMID: 26105251.
23. Berks D., Duvekot J.J., Basalan H., De Maat M.P., Steegers E.A., Visser W. Associations between phenotypes of preeclampsia and thrombophilia. Eur J Obstet Gynecol Reprod Biol. 2015; 194: 199–205. DOI: https://doi.org/10.1016/j.ejogrb.2015.09.021 Epub 2015 Sep 28. PMID: 26444331.
24. Lidan H., Jianbo W., Liqin G., Jifen H., Lin L., Xiuyan W. The diagnostic efficacy of thrombelastography (TEG) in patients with preeclampsia and its association with blood coagulation. Open Life Sci. 2019; 14: 335–41. DOI: https://doi.org/10.1515/biol-2019-0037 PMID: 33817167; PMCID: PMC7874822.
25. Marín R., Chiarello D.I., Abad C., Rojas D., Toledo F., Sobrevia L. Oxidative stress and mitochondrial dysfunction in early-onset and late-onset preeclampsia. Biochim Biophys Acta Mol Basis Dis. 2020; 1866 (12): 165961. DOI: https://doi.org/10.1016/j.bbadis.2020.165961 Epub 2020 Sep 8. PMID: 32916282.
26. Bellos I., Pergialiotis V., Loutradis D., Daskalakis G. The prognostic role of serum uric acid levels in preeclampsia: a meta-analysis. J Clin Hypertens (Greenwich). 2020; 22 (5): 826–34. DOI: https://doi.org/10.1111/jch.13865 Epub 2020 Apr 27. PMID: 32338457; PMCID: PMC8030030.
27. Mokhtar E.R., Abd El-Hakam F.A., Ebriheem E.E., El Attar S., Hassan M.M., Al Anany M.G. Maternal serum perlecan and ischemia modified albumin levels as biomarkers of preeclampsia severity. Egypt J Immunol. 2022; 29 (3): 64–79. PMID: 35758970.
28. Mirkovic L., Tulic I., Stankovic S., Soldatovic I. Prediction of adverse maternal outcomes of early severe preeclampsia. Pregnancy Hypertens. 2020; 22: 144–50. DOI: https://doi.org/10.1016/j.preghy.2020.09.009 Epub 2020 Sep 17. PMID: 32979729.
29. Li W., Lin X., Chen Y., Liu K., Yang W., Zeng S., et al. Predictive value of the second-trimester fibronectin concentration for severe preeclampsia: a prospective nested case-control study in China. J Obstet Gynaecol Res. 2022; 48 (7): 1721–31. DOI: https://doi.org/10.1111/jog.15259 Epub 2022 Apr 6. PMID: 35385197.
30. Shalina R.I., Kanzapetov M.R. Antioxidants and their role in obstetric practice. Ginekologiya [Gynecology]. 2013; 15 (5): 84–7. (in Russian)